TP73 and breast carcinoma: Previous research also indicates that TP73-AS1 competes with HMGB1 for miR-200a binding in hepatocellular carcinoma cells [15] and promotes breast cancer cell proliferation by acting as competing endogenous RNA (ceRNA) in sponging miR-200a [16,17].